Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > What is the Time Line for some Cancer Free News

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Jun 07, 2021 1:00pm

163 Views

Post# 33340773

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:What is the Time Line for some Cancer Free News

https://pubmed.ncbi.nlm.nih.gov/30522445/

https://pubmed.ncbi.nlm.nih.gov/30522445/

DJDawg wrote:
ah. got it.

So if we were just consider the total set of patients who got optimized dose AND optimized procedure, that would be:

phase 1b: 2 patients
phase 2 reset: 7 patients.

We have 90 day data on 5 of the 9.
Of the 5 that we have data on, 4 are CR at 90. 1 is NR or passed away (debated, unknown)

That helps to clear that up.

But what about this 11 that came up in the annual report? Where are they in the track? It is too bad that the company doesn't mention when they will have updated data post optimized treatment and dosage.

Other things I was thinking about because I don't have a hobby.

In the TLT main investor powerpoint, there is one promising drug listed called electromotive mitomycin. 58% CR at 6m. Also listed as approved but not available. Why? If it works that well it should be out there?